Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (221-230 of 528) with videos related to

Pageof 53
Sort By:
Frontiers in Oncology|August 11, 2015
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer ProgressionTamara Mirzapoiazova, Nurbek Mambetsariev, Frances E Lennon, et al.
Cancers|February 23, 2020
Association of <i>TGF-β1</i> Polymorphisms with Breast Cancer Risk: A Meta-Analysis of Case-Control Studies †B Madhu Krishna, Samir Jana, Aditya K Panda, et al.
American Journal of Clinical Oncology|February 12, 2019
Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung AdenocarcinomaRohan Gupta, Idoroenyi Amanam, Syed Rahmanuddin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2011
Multicenter phase II trial of Motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancerMartin J Edelman, Gregory Otterson, Joseph Leach, et al.
Journal of Proteomics|September 25, 2018
2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cellsLokesh D Nagaprashantha, Jyotsana Singhal, Shireen Chikara, et al.
Pigment Cell & Melanoma Research|January 14, 2010
PAX3 and SOX10 activate MET receptor expression in melanomaJoseph B Mascarenhas, Erica L Littlejohn, Rebecca J Wolsky, et al.
The Annals of Thoracic Surgery|August 28, 2012
Quality of life after radical pleurectomy decortication for malignant pleural mesotheliomaNathan M Mollberg, Yalini Vigneswaran, Hedy L Kindler, et al.
Cancer Research|February 5, 2011
Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletionsWanqing Liu, Lijun He, Jacqueline Ramírez, et al.
Seminars in Oncology|March 23, 2011
Personalized treatment of lung cancerRavi Salgia, Thomas Hensing, Nicholas Campbell, et al.
Lung Cancer (Amsterdam, Netherlands)|May 5, 2015
A new PET/CT volumetric prognostic index for non-small cell lung cancerHao Zhang, Kristen Wroblewski, Yulei Jiang, et al.
Pageof 53

Showing results (221-230 of 528) with videos related to

Sort By:
Pageof 53
Frontiers in Oncology|August 11, 2015
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer ProgressionTamara Mirzapoiazova, Nurbek Mambetsariev, Frances E Lennon, et al.
Cancers|February 23, 2020
Association of <i>TGF-β1</i> Polymorphisms with Breast Cancer Risk: A Meta-Analysis of Case-Control Studies †B Madhu Krishna, Samir Jana, Aditya K Panda, et al.
American Journal of Clinical Oncology|February 12, 2019
Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung AdenocarcinomaRohan Gupta, Idoroenyi Amanam, Syed Rahmanuddin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2011
Multicenter phase II trial of Motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancerMartin J Edelman, Gregory Otterson, Joseph Leach, et al.
Journal of Proteomics|September 25, 2018
2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cellsLokesh D Nagaprashantha, Jyotsana Singhal, Shireen Chikara, et al.
Pigment Cell & Melanoma Research|January 14, 2010
PAX3 and SOX10 activate MET receptor expression in melanomaJoseph B Mascarenhas, Erica L Littlejohn, Rebecca J Wolsky, et al.
The Annals of Thoracic Surgery|August 28, 2012
Quality of life after radical pleurectomy decortication for malignant pleural mesotheliomaNathan M Mollberg, Yalini Vigneswaran, Hedy L Kindler, et al.
Cancer Research|February 5, 2011
Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletionsWanqing Liu, Lijun He, Jacqueline Ramírez, et al.
Seminars in Oncology|March 23, 2011
Personalized treatment of lung cancerRavi Salgia, Thomas Hensing, Nicholas Campbell, et al.
Lung Cancer (Amsterdam, Netherlands)|May 5, 2015
A new PET/CT volumetric prognostic index for non-small cell lung cancerHao Zhang, Kristen Wroblewski, Yulei Jiang, et al.
Pageof 53